Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucagon and the circulation.

A E Farah

    Pharmacological Reviews
    |September 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Glucagon, a hormone, impacts blood pressure by affecting vascular resistance and has direct tubular effects in the kidney, potentially influencing electrolyte excretion and contributing to diabetic kidney changes. Its cardiac effects resemble beta-adrenergic agents but are nonarrhythmogenic.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The influence of rate of administration upon the lethal dose of cardiac glycosides.

    The Journal of pharmacology and experimental therapeutics·2010
    Same author

    Prevalence of hepatitis B surface antigen in pregnant Lebanese women.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·1997
    Same author

    Hepatitis C virus antibodies in pregnant Lebanese women.

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·1997
    Same author

    The role of cyclic AMP and the dihydropyridine-sensitive channels on the mechanism of action of milrinone (Corotrope).

    Journal of cardiovascular pharmacology·1989
    Same author

    Seroepidemiology of the human immunodeficiency virus in Lebanon. Preliminary evaluation.

    Le Journal medical libanais. The Lebanese medical journal·1989
    Same author

    Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons.

    Le Journal medical libanais. The Lebanese medical journal·1989
    Same journal

    Aryl hydrocarbon receptor pharmacology-mechanisms, ligands, and therapeutic potential.

    Pharmacological reviews·2026
    Same journal

    Mast cell proteases and their significance in physiology, pathology, and therapeutic approaches.

    Pharmacological reviews·2026
    Same journal

    Translational medications development for methamphetamine use disorder: A systematic review of preclinical, human laboratory, and clinical research.

    Pharmacological reviews·2026
    Same journal

    Reharnessing the therapeutic potential of gallium-based compounds in oncology: From the laboratory to the clinic.

    Pharmacological reviews·2026
    Same journal

    Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions.

    Pharmacological reviews·2026
    Same journal

    International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors.

    Pharmacological reviews·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Nephrology
    • Cardiology

    Background:

    • Glucagon is a hormone known to affect vascular resistance and blood pressure.
    • Species-specific responses to glucagon in various vascular beds have been observed.
    • Its role in renal function and cardiac activity is complex and not fully elucidated.

    Purpose of the Study:

    • To explore the vasodilatory effects of glucagon and its impact on vascular resistance.
    • To investigate the direct tubular effects of glucagon in the kidney and their potential link to diabetic nephropathy.
    • To examine the cardiac effects of glucagon, including its inotropic and chronotropic properties and antiarrhythmogenic potential.

    Main Methods:

    • Review of existing literature on glucagon's physiological effects.

    Related Experiment Videos

  • Analysis of studies investigating glucagon's impact on renal plasma flow, glomerular filtration, and electrolyte excretion.
  • Examination of research on glucagon's effects on cardiac muscle contractility and rhythm.

    • Main Results:

    • Glucagon reduces vascular resistance, particularly in the splanchnic and hepatic vasculature.
    • In the kidney, glucagon can increase electrolyte excretion via direct tubular effects, potentially mediated by cAMP and prostaglandins.
    • Glucagon exhibits positive inotropic and chronotropic effects on cardiac muscle, with species-dependent variations and notable antiarrhythmogenic properties.

    Conclusions:

    • Glucagon's vasodilatory and renal tubular effects have implications for blood pressure regulation and kidney function, particularly in diabetes.
    • The cardiac effects of glucagon, while resembling beta-adrenergic agents, appear to be distinct in their nonarrhythmogenic profile.
    • Further research is warranted to fully understand the mechanisms underlying glucagon's diverse physiological actions.